Interferon-, a Th 1 Cytokine , Regulates Fat Inflammation

Adipose tissue (AT) can accumulate macrophages and secrete several inflammatory mediators. Despite its pivotal role in the progression of chronic inflammatory processes such as atherosclerosis, the adaptive role of immunity in obesity remains poorly explored. Visceral AT of diet-induced obese C57BL/6 mice had higher numbers of both CD4+ and CD8+ T cells than lean controls, monitored by flow cytometry. When stimulated in vitro, T cells from obese AT produced more interferon (IFN)&ggr; than those from controls. AT from obese animals also had more cells expressing I-Ab, a mouse class II histocompatibility marker implicated in antigen presentation, as determined by immunostaining. Differentiated 3T3-L1 cells stimulated with recombinant IFN&ggr; or T-helper 1–derived supernatant produced several chemokines and their mRNAs. Obese IFN&ggr;-deficient animals had significantly reduced AT expression of mRNA-encoding inflammatory genes such as tumor necrosis factor-&agr; and monocyte chemoattractant protein-1, decreased AT inflammatory cell accumulation, and better glucose tolerance than control animals consuming the same diet. Obese mice doubly deficient for IFN&ggr; receptor and apolipoprotein (Apo)E on a mixed 129SvEv/C57BL/6 (129/B6) genetic background, despite exhibiting similar AT mRNA levels of tumor necrosis factor-&agr; and monocyte chemoattractant protein-1 as 129/B6-ApoE−/− controls, had decreased expression of important T cell–related genes, such as IFN&ggr;-inducible protein-10 and I-Ab, and lower plasma triglycerides and glucose. These results indicate a role for T cells and IFN&ggr;, a prototypical T-helper 1 cytokine, in regulation of the inflammatory response that accompanies obesity.

[1]  P. Libby,et al.  The multiple facets of the fat tissue. , 2008, Thyroid : official journal of the American Thyroid Association.

[2]  G. Hansson,et al.  Innate immunity, macrophage activation, and atherosclerosis , 2007, Immunological reviews.

[3]  J J Chen,et al.  Selection of differentially expressed genes in microarray data analysis , 2007, The Pharmacogenomics Journal.

[4]  K. Flegal,et al.  Epidemiology of Obesity , 2014 .

[5]  Leif E. Peterson,et al.  T-Cell Accumulation and Regulated on Activation, Normal T Cell Expressed and Secreted Upregulation in Adipose Tissue in Obesity , 2007, Circulation.

[6]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[7]  Christian Weber,et al.  Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[9]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[10]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[11]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[12]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[13]  G. Hansson,et al.  Inflammation and atherosclerosis. , 2006, Annual review of pathology.

[14]  Ian Janssen,et al.  Vascular Risks and Management of Obesity in Children and Adolescents , 2006, Vascular health and risk management.

[15]  Ildikó Kriszbacher,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.

[16]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[17]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[18]  F. Mach,et al.  Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice , 2004, Circulation research.

[19]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[20]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[21]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[22]  J. Pober,et al.  Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.

[23]  J. Pober,et al.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. , 2000, Nature.

[24]  P. Libby,et al.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. , 1999, The Journal of clinical investigation.

[25]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[26]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[27]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[28]  D. Easty,et al.  Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[30]  K. Feingold,et al.  In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. , 1992, Endocrinology.

[31]  G. Hansson,et al.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.

[32]  W. Fiers,et al.  Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. , 1992, Endocrinology.

[33]  A. Clowes,et al.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. , 1988, Circulation research.

[34]  R. Krishnan,et al.  Effects of γ-Interferon on the Endocrine System: Results from a Phase I Study , 1987 .

[35]  R. Krishnan,et al.  Effects of gamma-interferon on the endocrine system: results from a phase I study. , 1987, Cancer research.

[36]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.